02/03/2016
Federal Register Notice: FDA is making available a draft guidance for industry and FDA staff entitled Human Factors Studies and Re...01/28/2016
Federal Register Notice: FDA seeks public comments on the procedure by which an applicant may obtain an assignment or designation ...01/28/2016
Federal Register Notice: FDA is making available a revised draft guidance for industry on lamotrigine extended-release tablets ent...01/28/2016
Federal Register Notice: FDA is making available additional draft and revised draft product-specific bioequivalence (BE) recommend...01/28/2016
Federal Register Notice: FDA’s Cincinnati District and Xavier University will co-sponsor a public conference 5/4-6 entitled ...01/22/2016
Federal Register Notice: FDA is renewing the Pharmaceutical Science and Clinical Pharmacology Advisory Committee (formerly known a...01/22/2016
Federal Register Notice: FDA is making available a draft guidance entitled Postmarket Management of Cybersecurity in Medical Devic...01/22/2016
Federal Register Notice: FDA is correcting a 1/19 Federal Register notice announcing the Arthritis Advisory Committee meeting set ...